The effects of GLP-1RAs on colorectal and other cancer risk Clinical studies have demonstrated that the use of GLP-1RAs can reduce the risk of colorectal cancer, and the protective effect appears to be positively correlated with the duration of therapy
In general, in 70% of the cases, androgen receptor gene mutations are transmitted in an X-linked recessive manner, but in 30% the mutations arise de novo
It supports brain function, energy metabolism, and the conversion of fats into energy, making it beneficial for mental focus and vitality
Recent advances, primarily based on three landmark clinical studies, namely, Nix-TB, ZeNix, and TB PRACTECAL (Conradie et al., 2020
Since Semaglutide GLP-1 has a long half-life, one injection per week is sufficient, making it a convenient option compared to daily medications